Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Price

Showing results (561-570 of 635) with videos related to

Pageof 64
Sort By:
Pragmatic and Observational Research|January 26, 2024
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICSDavid Price, William Henley, José Eduardo Delfini Cançado, et al.
Pragmatic and Observational Research|June 3, 2021
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical OutcomesDavid Price, Rupert Jones, Pascal Pfister, et al.
The European Respiratory Journal|July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 24, 2019
Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter studyKyu Yean Kim, Marc Miravitlles, Pawel Sliwinski, et al.
Plos One|October 19, 2021
Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported informationBrooklyn Stanley, Andrew Davis, Rupert Jones, et al.
Annals of Family Medicine|March 27, 2023
Health TAPESTRY Ontario: A Multi-Site Randomized Controlled Trial Testing Implementation and ReproducibilityDee Mangin, Larkin Lamarche, Doug Oliver, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Trials|June 11, 2015
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trialGraham Devereux, Seonaidh Cotton, Peter Barnes, et al.
Pragmatic and Observational Research|December 18, 2024
Preserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary DiseaseAlexander Evans, Yasir Tarabichi, Wilson D Pace, et al.
Implementation Science : IS|April 6, 2016
A protocol for a pragmatic randomized controlled trial using the Health Teams Advancing Patient Experience: Strengthening Quality (Health TAPESTRY) platform approach to promote person-focused primary healthcare for older adultsLisa Dolovich, Doug Oliver, Larkin Lamarche, et al.
Pageof 64

Showing results (561-570 of 635) with videos related to

Sort By:
Pageof 64
Pragmatic and Observational Research|January 26, 2024
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICSDavid Price, William Henley, José Eduardo Delfini Cançado, et al.
Pragmatic and Observational Research|June 3, 2021
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical OutcomesDavid Price, Rupert Jones, Pascal Pfister, et al.
The European Respiratory Journal|July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 24, 2019
Comparison of clinical baseline characteristics between Asian and Western COPD patients in a prospective, international, multicenter studyKyu Yean Kim, Marc Miravitlles, Pawel Sliwinski, et al.
Plos One|October 19, 2021
Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported informationBrooklyn Stanley, Andrew Davis, Rupert Jones, et al.
Annals of Family Medicine|March 27, 2023
Health TAPESTRY Ontario: A Multi-Site Randomized Controlled Trial Testing Implementation and ReproducibilityDee Mangin, Larkin Lamarche, Doug Oliver, et al.
The New England Journal of Medicine|May 6, 2011
Leukotriene antagonists as first-line or add-on asthma-controller therapyDavid Price, Stanley D Musgrave, Lee Shepstone, et al.
Trials|June 11, 2015
Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trialGraham Devereux, Seonaidh Cotton, Peter Barnes, et al.
Pragmatic and Observational Research|December 18, 2024
Preserved Ratio Impaired Spirometry in US Primary Care Patients Diagnosed with Chronic Obstructive Pulmonary DiseaseAlexander Evans, Yasir Tarabichi, Wilson D Pace, et al.
Implementation Science : IS|April 6, 2016
A protocol for a pragmatic randomized controlled trial using the Health Teams Advancing Patient Experience: Strengthening Quality (Health TAPESTRY) platform approach to promote person-focused primary healthcare for older adultsLisa Dolovich, Doug Oliver, Larkin Lamarche, et al.
Pageof 64